| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198112033052301 |
| P698 | PubMed publication ID | 7029275 |
| P2093 | author name string | Adams JM | |
| Friedman Z | |||
| Hittner HM | |||
| Garcia-Prats JA | |||
| Rudolph AJ | |||
| Godio LB | |||
| Monaco WA | |||
| Kautz JA | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preterm infant | Q45051448 |
| P304 | page(s) | 1365-1371 | |
| P577 | publication date | 1981-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants | |
| P478 | volume | 305 |
| Q34213030 | Acute proliferative retrolental fibroplasia: multivariate risk analysis. |
| Q68877675 | An interpretation of retinopathy of prematurity in terms of spindle cells: relationship to vitamin E prophylaxis and cryotherapy |
| Q74180092 | Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status |
| Q33748019 | Antioxidant vitamin supplements: update of their potential benefits and possible risks |
| Q30790216 | Association of candidemia and retinopathy of prematurity in very low birthweight infants |
| Q33700370 | Basic problems in controlled trials |
| Q40174737 | Care of the Infant with Retinopathy of Prematurity |
| Q40165985 | Cellular and subcellular events in retinopathy of oxygen toxicity with a preliminary report on the preventive role of vitamin E and gamma-aminobutyric acid: a studyin vitro |
| Q41765527 | Clinical factors associated with retinopathy of prematurity |
| Q39587740 | Controversies in neonatal nutrition |
| Q72720095 | Current concepts of the effect of oxygen on the developing retina |
| Q70271763 | Current therapy of retrolental fibroplasia. Retinopathy of prematurity |
| Q34526885 | Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity |
| Q47262174 | Developmental Follow-Up of Low-Birth-Weight Infants |
| Q70005477 | Disposition of intravenously administered pharmacologic doses of vitamin E in newborn rabbits |
| Q33587865 | Dosage and formulation issues: oral vitamin E therapy in children |
| Q79181684 | Effect of Dexamethasone Therapy on Serum Vitamin E Concentrations in Premature Infants with Bronchopulmonary Dysplasia |
| Q49345179 | Effect of Maternal Smoking on Plasma and Urinary Measures of Vitamin E Isoforms in the First Month after Extreme Preterm Birth |
| Q72526370 | Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial |
| Q38626864 | Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial |
| Q70257829 | Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study |
| Q39634435 | Free radicals in medicine. II. Involvement in human disease |
| Q73503905 | Gallium-desferrioxamine protects the cat retina against injury after ischemia and reperfusion |
| Q39844905 | Hyperbaric oxygen in the treatment of burns. |
| Q47228317 | Increased morbidity in low-birth-weight survivors with severe retrolental fibroplasia |
| Q48373840 | Intraventricular hemorrhage: emphasis on prevention |
| Q35662653 | Long-term visual outcomes in extremely low-birth-weight children (an American Ophthalmological Society thesis) |
| Q40146685 | Medical Uses of Vitamin E |
| Q88878915 | MnTBAP or Catalase Is More Protective against Oxidative Stress in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia than Their Co-Administration (EUK-134) |
| Q42249971 | Muscular calcification following injection of vitamin E in newborn infants |
| Q69818116 | Necrotizing myopathy with paracrystalline inclusion bodies in hypervitaminosis E |
| Q71862173 | Neonatal oxygen toxicity--is it preventable? |
| Q53427644 | Observations on the retinopathy of prematurity. |
| Q42610126 | Ocular morbidity in infants of very low birth weight |
| Q40466296 | Oxygen free radicals and human disease |
| Q41943258 | Pathogenic mechanism of retinopathy of prematurity: a controversial explanation for the efficacy of oral and intramuscular vitamin E supplementation and cryotherapy |
| Q26772889 | Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity |
| Q53907450 | Physiological and therapeutic role of vitamin E in humans: an update. |
| Q42116200 | Prevention of intraventricular haemorrhage by fresh frozen plasma |
| Q70444381 | Protective effect of vitamin E against intraventricular haemorrhage in premature babies |
| Q93494814 | Protective effect of vitamin E against intraventricular haemorrhage in premature babies |
| Q40146713 | Recent Advances in Hyaline Membrane Disease |
| Q34713927 | Retinal detachment in young premature infants with acute retrolental fibroplasia. Thirty-two new cases. |
| Q71247652 | Retinal disorders of childhood |
| Q68206886 | Retinopathy of prematurity |
| Q72334349 | Retinopathy of prematurity |
| Q72867968 | Retinopathy of prematurity |
| Q35066325 | Retinopathy of prematurity: clinical implications of retinal development |
| Q33261163 | Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention. |
| Q34076959 | Retinopathy of prematurity: prevalence and treatment over a 20 year period at Pennsylvania Hospital |
| Q33644252 | Retinopathy of prematurity: review of a four-year period |
| Q39551489 | Retinopathy of prematurity: what causes it? |
| Q71859915 | Retrolental fibroplasia may not be preventable |
| Q53776157 | Serum alpha-tocopherol levels after high-dose enteral vitamin E administration in patients with acute respiratory failure. |
| Q41668810 | Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. |
| Q69560078 | Studies on the tocopherol status in blood serum of premature babies and infants |
| Q70409961 | Suppression of severe retinopathy of prematurity with vitamin E supplementation. Ultrastructural mechanism of clinical efficacy |
| Q70240432 | The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia |
| Q30668058 | The management of retinopathy of prematurity |
| Q39551503 | The role of vitamin E therapy in high-risk neonates. |
| Q69382977 | The treatment of advanced retinopathy of prematurity by cryotherapy and scleral buckling surgery |
| Q44560863 | Tissue α-tocopherol status during late fetal and early neonatal life of the guinea-pig |
| Q56766483 | Ultrastructural evaluation of the retina in retinopathy of prematurity and correlations with vitamin E therapy |
| Q52669201 | Update on Vitamin E and Its Potential Role in Preventing or Treating Bronchopulmonary Dysplasia. |
| Q72712095 | Use of methyl prednisolone and antioxidants in mercuric chloride-induced experimental vasculitis |
| Q49917764 | Vitamin D and regulation of vascular cell function |
| Q70307328 | Vitamin E and Retrolental Fibroplasia: Ultrastructural Mechanism of Clinical Efficacy |
| Q69910369 | Vitamin E and retinopathy of prematurity. Follow-up at one year |
| Q69500324 | Vitamin E and retinopathy of prematurity: still controversial |
| Q70271765 | Vitamin E and retrolental fibroplasia. Improved visual outcome with early vitamin E |
| Q40182268 | Vitamin E deficiency anemia in newborn infants. |
| Q77946874 | Vitamin E for ROP |
| Q74034570 | Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials |
| Q59066922 | Vitamin E protects against retinopathy of prematurity through action on spindle cells |
| Q24247665 | Vitamin E supplementation for prevention of morbidity and mortality in preterm infants |
| Q36293170 | Vitamin E therapy in retinopathy of prematurity |
| Q40116538 | Vitamin therapy in the absence of obvious deficiency. What is the evidence? |
Search more.